NCT04634500View on ClinicalTrials.gov

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

November 3, 2021

Study Completion Date

November 3, 2021

Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG

Dapagliflozin

Dapagliflozin Tablet

Trial Locations (1)

Unknown

Daewoong pharmatceutical, Soeul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY